The molecular basis of ACH was elucidated in 1994 as a heterozygous pathogenic variant in the fibroblast growth factor receptor 3 (FGFR3) gene on chromosome 4p16.3 (Rousseau et al., 1994; Shiang et al., 1994). The gene discussed is FGFR3; the disease is achondroplasia.